Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,057 | 589 | 37.4% |
| Consulting Fee | $11,400 | 5 | 35.4% |
| Unspecified | $3,567 | 2 | 11.1% |
| Travel and Lodging | $3,450 | 11 | 10.7% |
| Honoraria | $1,600 | 1 | 5.0% |
| Education | $133.40 | 5 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | $16,736 | 21 | $0 (2022) |
| Amgen Inc. | $5,638 | 307 | $0 (2024) |
| Eli Lilly and Company | $3,567 | 2 | $0 (2021) |
| ABBVIE INC. | $1,456 | 63 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,158 | 80 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,010 | 48 | $0 (2024) |
| Lilly USA, LLC | $727.87 | 32 | $0 (2021) |
| GENZYME CORPORATION | $283.52 | 10 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $266.80 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $194.55 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,273 | 102 | Amgen Inc. ($958.97) |
| 2023 | $2,204 | 95 | Amgen Inc. ($1,009) |
| 2022 | $16,888 | 108 | Ultragenyx Pharmaceutical Inc. ($15,093) |
| 2021 | $4,143 | 81 | Ultragenyx Pharmaceutical Inc. ($1,624) |
| 2020 | $3,568 | 60 | Eli Lilly and Company ($2,375) |
| 2019 | $1,333 | 73 | Amgen Inc. ($717.10) |
| 2018 | $923.86 | 55 | Amgen Inc. ($310.08) |
| 2017 | $873.89 | 39 | AbbVie, Inc. ($254.01) |
All Payment Transactions
613 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: Dermatology | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Dermatology | ||||||
| 10/29/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $171.22 | General |
| 10/24/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $39.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Dermatology | ||||||
| 10/11/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Inflammation | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $117.44 | General |
| Category: Inflammation and Autoimmunity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | Eli Lilly and Company | $3,567 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 281 | 648 | $95,463 | $57,871 |
| 2022 | 6 | 243 | 634 | $90,460 | $55,475 |
| 2021 | 6 | 279 | 731 | $102,348 | $64,521 |
| 2020 | 5 | 274 | 704 | $99,325 | $53,242 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 398 | $64,078 | $39,498 | 61.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 126 | $16,142 | $9,028 | 55.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $11,625 | $8,083 | 69.5% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2023 | 17 | 25 | $1,718 | $795.36 | 46.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 38 | $1,900 | $467.40 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 364 | $58,910 | $36,914 | 62.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 155 | $20,057 | $11,770 | 58.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $8,090 | $5,546 | 68.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 48 | $2,400 | $610.79 | 25.4% |
| 99423 | Online digital evaluation and management service for an established patient for up to 7 days, total time 21 or more minutes | Office | 2022 | 14 | 14 | $672.00 | $417.57 | 62.1% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2022 | 11 | 11 | $330.88 | $216.58 | 65.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 144 | 436 | $70,196 | $46,034 | 65.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 150 | $19,217 | $11,072 | 57.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 40 | 40 | $7,400 | $5,446 | 73.6% |
| 99423 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 21 or more minutes | Office | 2021 | 22 | 27 | $1,695 | $866.84 | 51.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 14 | 60 | $3,000 | $751.20 | 25.0% |
| 99422 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes | Office | 2021 | 16 | 18 | $840.88 | $351.04 | 41.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 413 | $66,493 | $36,491 | 54.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 150 | $19,217 | $9,554 | 49.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 43 | 43 | $8,115 | $5,350 | 65.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 30 | $2,100 | $1,005 | 47.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 68 | $3,400 | $843.07 | 24.8% |
About Dr. Hans Richard Barthel, M.D
Dr. Hans Richard Barthel, M.D is a Rheumatology healthcare provider based in Santa Barbara, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003827999.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hans Richard Barthel, M.D has received a total of $32,207 in payments from pharmaceutical and medical device companies, with $2,273 received in 2024. These payments were reported across 613 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($12,057).
As a Medicare-enrolled provider, Barthel has provided services to 1,077 Medicare beneficiaries, totaling 2,717 services with total Medicare billing of $231,110. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Santa Barbara, CA
- Active Since 08/10/2006
- Last Updated 02/20/2008
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1003827999
Products in Payments
- Crysvita (Drug) $13,948
- Enbrel (Biological) $3,693
- BENLYSTA (Biological) $1,010
- EVENITY (Biological) $958.22
- RINVOQ (Biological) $716.77
- COSENTYX (Biological) $659.12
- TALTZ (Drug) $514.11
- COSENTYX (Drug) $470.86
- Otezla (Drug) $438.71
- SKYRIZI (Biological) $301.57
- SAPHNELO (Biological) $266.80
- KEVZARA (Drug) $263.98
- Humira (Biological) $254.01
- Prolia (Biological) $227.12
- SIMPONI ARIA (Biological) $120.31
- Actemra (Biological) $119.85
- KEVZARA (Biological) $118.54
- ACTHAR (Biological) $114.77
- Rinvoq (Biological) $112.81
- FORTEO (Drug) $109.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Santa Barbara
Stuart Segal, M.d, M.D
Rheumatology — Payments: $162,377
Christian Powell
Rheumatology — Payments: $21,653
Sara Taroumian, M.d, M.D
Rheumatology — Payments: $17,319
Susan Lemon, Do, DO
Rheumatology — Payments: $14,104
Dr. Timothy Spiegel, M.d, M.D
Rheumatology — Payments: $12,362
Guy Clark, Md, MD
Rheumatology — Payments: $3,579